Background—Little is known about the coagulation factors as predictors of cerebral bleeding
in rt-PA thrombolysis. The aim of this study was to determine what early coagulation …

Background and Purpose—Intracerebral hemorrhage is the most serious complication of
thrombolytic therapy for stroke. We explored factors associated with this complication in the …

Acute ischemic stroke remains a major public health concern, with low national treatment
rates for the condition, demonstrating a disconnection between the evidence of treatment …

Background Studies have demonstrated that thrombolytic therapy for acute stroke can be
given safely and effectively in study settings with experienced clinicians, but the patient …

目的评价重组组织型纤溶酶原激活剂(rt-PA) 6 h 内静脉溶栓治疗急性脑梗死的疗效及剂量.
方法将符合入选标准的206 例患者随机分为A, B, C 组, A 组rt-PA 0.9 mg/kg, B 组rt-PA 0.7 …

Background and Purpose—Only 2% to 4% of patients with acute ischemic stroke receive
thrombolytic therapy resulting from the current strict inclusion criteria among other issues …

▪ Abstract Stroke is the most common life-threatening neurologic disease and the leading
cause of serious long-term disability. The advent of new treatment options for selected …

Objective To determine whether warfarin-treated patients with an international normalized
ratio less than 1.7 who receive intravenous tissue plasminogen activator for acute ischemic …

The treatment of acute stroke changed dramatically since the publication of the NINDS trail
for IV rt-PA for acute stroke. While this was not the first trial, it was the first positive trial …

This policy was developed by a joint writing panel of the American College of Emergency
Physicians and the American Academy of Neurology. The panel reviewed the literature to …